Source: Thailand Medical News Dec 10, 2019 4 years, 7 months, 2 weeks, 3 days, 4 hours, 3 minutes ago
Researchers from the Developmental and Stem Cell Biology Department at the Institut Pasteur have concluded a study that sheds light on the mechanisms of senescence, by identifying a key protein known as
CSB that associated with
ageing.
Currently,
ageing is a dramatic public health issue in the face of the current demographic changes: the proportion of 60 and over in the world's population will almost double by 2050. In this context, the new discovery has just broadened scientific knowledge.
Most old people die of noncommunicable diseases such as heart disease, cancer and diabetes, rather than infectious or parasitic diseases, even in developing countries. Thus,
ageing is a major public health issue and the Institut Pasteur is committed to being a major player in research in this area. A better understanding of the fundamental mechanisms that lead to
ageing will pave the way towards ultimately healthier
ageing, which is a major socioeconomic issue for the coming decades.
Typically,
senescence, which is a process that limits proliferation of damaged cells in response to various types of stress, has been associated to
ageing. Accumulation of senescent cells in tissues may contribute to organ degeneration and age-related diseases. As a result, clearance of these cells has been associated with slower
ageing and longer healthspan in animal models.
Medical researchers from Institut Pasteur and CNRS demonstrated that progressive depletion of a protein drives proliferating cells into irreversible
ageing. Moreover, such a depletion is a very early trigger, and therefore a determinant of cellular
ageing, or
senescence.
This protein factor, called
CSB is involved in Cockayne syndrome, a disease affecting about one in every 200,000 people in European countries. The absence of
CSB protein or its dysfunction causes early
ageing, photosensitivity, progressive neurological disorders and intellectual deficit in patients with Cockayne syndrome.
Dr. Miria Ricchetti, head of the team Stability of Nuclear and Mitochondrial DNA within the Stem Cells and Development Unit at the Institut Pasteur told
Thailand Medical News, "We had previously shown that the absence or impairment of
CSB is also responsible for dysfunction of mitochondria, the power plant of cells. This new study reveals the very same alterations in replicative
senescence, a process strictly linked to physiological
ageing.”
The significance of the present discovery is that it shows that a factor that was considered to be stable in normal cells is instead progressively depleted when they proliferate. When this happens, the cell is irreparably committed to the dead end of
senescence.
The depletion or exhau
stion of
CSB is driven by epigenetic modifications (reversible and regulated modifications of gene expression, without altering the DNA) that block its expression at the DNA level. Moreover, a molecule previously identified by these researchers as being able to reverse the defects of Cockayne syndrome patient cells, is also able to attenuate the commitment of normal cells to
senescence.
Dr. Ricchetti concluded, "These studies demonstrate an important link between the pathological accelerated
ageing process and normal
aging, and also expose the
CSB protein as a key factor against cellular
ageing."
Reference: Clément Crochemore et al, CSB promoter downregulation via histone H3 hypoacetylation is an early determinant of replicative senescence, Nature Communications (2019). DOI: 10.1038/s41467-019-13314-y
